- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07593755
Evaluation of Toothpaste Effect in Volunteers With Dental Sensitivity
Comparative Clinical Trial to Evaluate the Efficacy of a Toothpaste in Subjects With Dental Hipersensitivity
The goal of this study is to learn if a toothpaste alone and together with mouthwash works to alleviate teeth hypersensitivity in adults. It will also learn about the safety of the product.
The main question it aims to answer is:
• Does the toothpaste help to improve signs of teeth hypersensitivity? Researchers will compare sensitive teeth toothpaste and use of sensitive teeth and mouthwash to a regular toothpaste to see if it works to improve teeth sensitivity.
Participants will:
- Use assigned products daily for 14 days
- Visit the clinic on the established days during 14 days for check-ups and evaluation
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Barcelona, Spagna
- Hospital Odontológico Universidad de Barcelona - Bellvitge
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Healthy female and male participants (no specific gender distributions required)
- Aged 18 years or older
- Participants presenting dental hyperesthesia with at least two hypersensitive teeth with a verbal rating scale (VRS) score greater than or equal to 1 after tactile stimulation, and a Schiff Cold Air Sensitivity Scale score greater than or equal to 1 at the initial visit (T0).
- Participants certifying the truthfulness of the personal data disclosed to the investigator.
- Participants able to understand the language used at the investigation centre and comprehend the information provided by the investigator.
- Participants able to follow the instructions provided by the investigator and comply with the study requirements and restrictions.
- Pharmacological therapy (except for therapies listed under non-inclusion criteria) must have been stable for at least one month, with no changes expected or planned during the study
- Commitment by the participants not to change the daily routine or lifestyle during the study.
- Participants who have not taken part in any other similar clinical study in the previous six months.
- Commitment by the participant not to use other oral hygiene products containing fluoride or ingredients such as hydroxyapatite during the study period.
Exclusion Criteria:
- Participants currently participating or planning to participate in other clinical trials.
- Participants deprived of liberty by administrative or judicial decision or under guardianship.
- Participants who cannot be contacted in the event of an emergency.
- Participants admitted to a healthcare or social institution.
- Participants planning hospitalization during the study period.
- Participants who have taken part in a similar study without respecting an adequate washout period (defined as the use of desensitizing agents within the last six months).
- Participants under pharmacological treatments that modify the evaluation of dental sensitivity or are incompatible with the requirements of the study.
- Participants with a history of active caries within the past 12 months or at risk for developing caries (e.g., multiple dental restorations, crowns with compromised margins) per examiners discretion.
- Participants with known allergies or sensitivities to any components of the investigational product.
- Women who are breastfeeding, pregnant, or unwilling to take the adequate contraceptive measures to avoid pregnancy during the study (for women of childbearing potential).
- Participants with acute, chronic, or progressive pathologies (including diabetes, cardiovascular and metabolic conditions) incompatible with the study requirements.
- Any tooth surface adjacent to those surfaces under investigation that in the opinion of the investigator have any other condition that produce symptoms confounding the evaluation of cervical dentin hypersensitivity.
- Participants with a medical history or taking medication, or wearing physical items (e.g., orthodontic braces) that could interfere with the study.
- Participants with a history of illegal drug use.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Dentifricio regolare
|
Toothpaste was used two times a day (after meals) during 14 days
|
|
Sperimentale: Desensitizing toothpaste
|
Toothpaste was used two times a day (after meals) during 14 days
|
|
Sperimentale: Desensitizing toothpaste with mouthwash
|
Toothpaste and mouthwash were used two times a day (after meals) during 14 days
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change from Baseline in dentine sensitivity comparing desensitizing toothpaste versus active comparator at 14 days
Lasso di tempo: From enrollment to the end of use at 14 days
|
From enrollment to the end of use at 14 days
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in dentine sensitivity from baseline in dentine sensitivity comparing desensitizing toothpaste group versus desensitizing toothpaste and mouthwash group at day 14.
Lasso di tempo: From baseline to day 14
|
From baseline to day 14
|
|
Change from baseline in pH at 14 days
Lasso di tempo: From baseline to day 14
|
From baseline to day 14
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ES0000395/2024
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Sensibilità dentale
-
Cairo UniversitySconosciutoBlack Stain Dental, Dental Black Stain, Black Stain*, Black Stain, Tooth Stains